Ignite Creation Date:
2024-05-11 @ 8:31 AM
Last Modification Date:
2024-10-26 @ 3:28 PM
Study NCT ID:
NCT06400264
Status:
WITHDRAWN
Last Update Posted:
2024-05-06
First Post:
2024-05-03
Brief Title:
Testing Nivolumab and BMS-986016 Relatlimab as Potentially Targeting Treatment in Cancers That Are LAG-3 and Have Mismatch Repair Deficiency MATCH - Subprotocol Z1M
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-01-17
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-01-17
Completion Date Type:
ACTUAL
First Submit Date:
2024-05-03
First Submit QC Date:
May 3 2024
Study First Post Date:
2024-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-05-03
Last Update Post Date:
2024-05-06
Last Update Post Date Type:
ACTUAL